Share This Author
Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition
- Jenny H. Lee, E. Shklovskaya, H. Rizos
- Biology, MedicineNature Communications
- 20 April 2020
TLDR
Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma
- M. Irvine, A. Stewart, Bernadette Pedersen, S. Boyd, R. Kefford, H. Rizos
- Biology, MedicineOncogenesis
- 1 September 2018
TLDR
Melanoma Cell State-Specific Responses to TNFα
TLDR
Interferon Signaling Is Frequently Downregulated in Melanoma
- S. Alavi, A. Stewart, R. Kefford, S. Y. Lim, E. Shklovskaya, H. Rizos
- Biology, MedicineFront. Immunol.
- 21 June 2018
Immune checkpoint inhibitors that block the programmed cell death protein 1/PD-L1 pathway have significantly improved the survival of patients with advanced melanoma. Immunotherapies are only…
Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma
- E. Shklovskaya, Jenny H. Lee, H. Rizos
- Biology, MedicineCancers
- 1 November 2020
TLDR
Uveal melanoma cell lines depend on multiple signaling pathways for survival
- John J Park, A. Stewart, H. Rizos
- BiologyAnnals of Oncology
- 1 October 2019
TLDR
Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
- R. Diefenbach, Jenny H. Lee, H. Rizos
- BiologyFrontiers in Oncology
- 12 April 2022
TLDR
Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signaling.
- John J Park, A. Stewart, H. Rizos
- BiologyCancer gene therapy
- 29 March 2022
TLDR